SCANSOURCE, INC. SEC Filings

SCANSource (SCSC) Form 144 reports proposed and completed sales of Common Stock by Michael Baur. The filing lists sales on 09/17/2025 of 102,031 shares for $4,587,290.91 and on 09/18/2025 of 47,969 shares for $2,126,809.23. Additional sales are reported on 12/12/2025 (982 shares for $41,334.35), 12/15/2025 (9,559 shares for $390,240.61), and 12/16/2025 (9,459 shares for $391,830.90).

The filing also records equity vesting events in August–September 2025 for performance shares and restricted stock units totaling listed grants of 1,721; 3,208; 7,802; and 12,269 shares on the dates shown. The Form 144 discloses transaction dates and amounts; cash‑flow treatment and registration specifics are those standard to Section 144 notices.

ScanSource, Inc. reported leadership changes in its senior management team. Effective March 16, 2026, Alexandre Conde, currently Senior Executive Vice President and Chief People Officer, will shift roles to become Senior Executive Vice President, Strategy. On March 6, 2026, the company hired Michael Webb, who will join ScanSource on March 16, 2026 as Senior Executive Vice President, Chief Human Resources Officer. These moves realign executive responsibilities around strategy and human resources while keeping Conde in a key leadership role focused on strategic initiatives.

ScanSource director Mathis Charles Alexander bought additional company stock in two open-market transactions. On 02/11/2026, he purchased 5,000 shares of common stock at a weighted average price of $35.32 and 1,000 shares at $34.63. Following these trades, he directly owned 24,793 shares. The larger purchase was executed through multiple trades between $34.92 and $35.63.

ScanSource, Inc. reported slightly higher revenue but mixed profit trends for the quarter and six months ended December 31, 2025. Quarterly net sales were $766.5 million, up from $747.5 million a year earlier, while net income edged down to $16.5 million from $17.1 million, with diluted EPS at $0.75 versus $0.70.

For the first six months, net sales were $1.51 billion compared with $1.52 billion, but net income rose to $36.4 million from $34.0 million, and diluted EPS increased to $1.63 from $1.39, helped by better gross margins and lower restructuring costs. Operating cash flow strengthened to $54.1 million from $38.6 million, supporting continued share repurchases and the October 2025 acquisition of DataXoom, which added goodwill and intangible assets.

ScanSource entered a new five-year credit agreement in December 2025, providing a $400 million multicurrency revolving facility and a $100 million term loan, and reduced total debt to $102.7 million from $136.1 million. Management highlights ongoing macroeconomic uncertainty, including inflation, tariffs and foreign exchange volatility, and is assessing the impact of new U.S. tax legislation enacted in 2025.

ScanSource, Inc. furnished an update on its recent financial and governance developments. The company issued a press release announcing financial results for its second quarter ended December 31, 2025, along with an unaudited earnings infographic, both of which are available as exhibits and on its website.

The filing also details Board leadership changes. Charles A. Mathis has been appointed Lead Independent Director and Chair of the Nominating and Corporate Governance Committee, succeeding Peter C. Browning, who remains on the Board and all its committees. Vernon J. Nagel succeeds Mr. Mathis as Chair of the Audit Committee.

A ScanSource, Inc. insider who is a director and officer serving as CEO, President and board chair reported multiple sales of company common stock. The Form 4 shows total sales of 20,000 shares of ScanSource common stock in transactions dated December 12, 15 and 16, 2025, all coded as sales.

Reported weighted average sale prices include 9,459 shares at $40.81 per share on December 15, 2025 and 7,281 shares at $41.53 per share on December 16, 2025, with additional smaller sales at other disclosed prices. After these transactions, the insider directly beneficially owns 182,512 shares of ScanSource common stock.

ScanSource, Inc. reported an insider stock transaction by its SEVP & CFO. On 12/11/2025, the officer sold 5,020 shares of ScanSource common stock in an open-market transaction coded "S" at a weighted average price of $42.30 per share.

After this sale, the insider directly owned 83,326 shares of ScanSource common stock. The reported weighted average price reflects multiple trades executed at prices ranging from $42.02 to $42.57 per share.

ScanSource, Inc. filed an 8-K/A confirming a planned change in independent auditors. The Audit Committee approved the transition after a competitive process on October 9, 2025. Grant Thornton LLP was dismissed effective November 6, 2025, immediately after the company filed its Form 10-Q for the quarter ended September 30, 2025. Deloitte & Touche LLP’s engagement began November 6, 2025 for the fiscal year ending June 30, 2026 and related interim periods commencing after September 30, 2025.

Grant Thornton’s audit reports for the fiscal years ended June 30, 2025 and June 30, 2024 contained no adverse opinion, disclaimer, or qualification as to uncertainty, audit scope, or accounting principles. The company reports no disagreements or reportable events with Grant Thornton through November 6, 2025. Grant Thornton’s concurrence letter is filed as Exhibit 16.1.

ScanSource, Inc. furnished an update on its first-quarter results for the period ended September 30, 2025. The company issued a press release and an earnings infographic, which are provided as Exhibits 99.1 and 99.2 and available on its website.

The materials are unaudited and are being furnished, not filed, under the Exchange Act. ScanSource also noted that an updated investor presentation will be posted on its website within approximately two weeks.